ALPHA TRIBE

Par Drugs and Chemicals LimitedBoard Meeting, 08-08-2026: Outcome of Board Meeting

08-08-2026 | 05:23 pm

Par Drugs and Chemicals' Board approved the financial results for the quarter, reporting revenue of ₹32.22 Cr and profit of ₹4.71 Cr. The board also greenlit new banking facilities, appointed NEO Alternative Asset Managers as Portfolio Manager, and approved vehicle asset updates including new purchases.

No comments yet. Be the first to comment!

All announcements from Par Drugs and Chemicals Limited